Results 331 to 340 of about 522,321 (423)

Luteinizing hormone receptor knockout mouse: What has it taught us?

Andrology, EarlyView.
Abstract Luteinizing hormone (LH), along with its agonist choriongonadotropin (hCG) in humans, is the key hormone responsible for the tropic regulation of the gonadal function. LH and hCG act through their cognate receptor, the luteinizing hormone/choriongonadotropin receptor (LHCGR; more appropriately LHR in rodents lacking CG), located in the testis ...
Ilpo T. Huhtaniemi
wiley   +1 more source

Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer. [PDF]

J Immunother Cancer
Tinoco JC, Saunders HI, Werner LR, Sun X, Chowanec EI, Heard A, Chalise P, Vahrenkamp JM, Wilson AE, Liu CX, Lei G, Wei J, Cros H, Mohammed H, Troester M, Perou C, Markiewicz MA, Gertz J, Balko JM, Hartman ZC, Hagan CR.   +20 more
europepmc   +1 more source

The aporetic dialogues of Modena on gender differences: Is it all about testosterone? Episode II: Empathy

Andrology, EarlyView.
Abstract The exploration of gender differences in non‐andrological fields was the core focus of a series of discussions, which took place at the Endocrinology Unit in Modena, Italy in the form of the aporetic dialogue of ancient Greece. This second episode reports the transcript of the actual debate on testosterone's role in defining empathic behavior ...
Giulia Brigante, Clara Lazzaretti, Ali Ahmad, Massimiliano Colzani, Filippo Vignali, Michele Zoli, Manuela Simoni   +6 more
wiley   +1 more source

Genistein Reduces Anxiety-like Behavior During Metestrus-Diestrus Phase Without Changing Estradiol or Progesterone Levels in Wistar Rats. [PDF]

Metabolites
Rodríguez-Landa JF, Olmos-Vázquez OJ, Quiñonez-Bailón CF, Guillén-Ruiz G, Limón-Vázquez AK, Cueto-Escobedo J, Rivadeneyra-Domínguez E, Bernal-Morales B.   +7 more
europepmc   +1 more source

Muscle strength changes and physical activity during gender‐affirming hormone therapy: A systematic review

Andrology, EarlyView.
Abstract Background Higher muscle strength is associated with improved overall health and lower mortality. Muscle strength changes during gender‐affirming hormone therapy is possibly linked to gender‐affirming hormone therapy modality, age at initiation, gender‐affirming hormone therapy duration, and physical activity.
Mathilde Kamp Nørlund, Louise Lehmann Christensen, Marianne Skovsager Andersen, Tine Taulbjerg Kristensen, Jan Frystyk, Jonas Mathiesen, Jakob Lindberg Nielsen, Dorte Glintborg   +7 more
wiley   +1 more source

Biochemical characterization of zebrafish Paqr5b. [PDF]

Biochem Biophys Rep
Sohan MSR, Hossain MF, Hossain S, Omori Y, Amin MT, Hasan ME, Tokumoto T.   +6 more
europepmc   +1 more source

Adrenal secretion rates and adrenal tissue concentrations of pregnenolone, progesterone, 11βOH‐androstenedione and some other steroids in young pigs and dogs

, 1969
Margarethe Holzbauer, Helen M. Newport
openalex   +2 more sources

Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial. [PDF]

J Natl Cancer Inst
Johansson A, Dar H, Nordenskjöld A, Perez-Tenorio G, Tobin NP, Yau C, Benz CC, Esserman LJ, van 't Veer LJ, Nordenskjöld B, Stål O, Fornander T, Lindström LS.   +12 more
europepmc   +1 more source

Progesterone and progestogens.

Australian prescriber, 2022
openaire   +2 more sources